Diagnosis
Pathology, imaging, molecular testing and clinical evaluation help define the disease.
● Professional oncology audiences for healthcare B2B outreach
DNA Precision oncology audience intelligence
Reach medical oncologists, hematologist-oncologists, radiation oncologists, surgical oncologists, cancer-center leaders, clinical research professionals and oncology decision-makers based on tumor focus, organization type, geography and business responsibility.
Medico Lists provides professional and organizational business-contact information. Patient records, diagnoses, treatment histories, clinical claims and confidential health information are not included.
Cancer-care market map
Cancer care is usually coordinated across diagnosis, treatment planning, therapy delivery, supportive services, research and long-term follow-up. The professionals involved can vary by tumor type, treatment approach and care setting.
Pathology, imaging, molecular testing and clinical evaluation help define the disease.
Oncologists, surgeons, radiologists and other specialists may review treatment options.
Systemic treatment, radiation, surgery, infusion and related services are coordinated.
Pharmacy, nursing, nutrition, navigation and symptom-management teams may participate.
Clinical trials, outcomes review, surveillance and survivorship programs continue the pathway.
The person evaluating a diagnostic platform may be different from the professional managing treatment, administering therapy, leading a research program or approving a vendor contract. A focused oncology audience should reflect those distinct responsibilities.
Treatment-discipline targeting
Select the clinical discipline that most closely matches the therapy, technology, service, educational program or recruitment objective.
Medical oncologists coordinate drug-based cancer treatment, including chemotherapy, immunotherapy, hormonal therapy and targeted therapy. They may work with pharmacy, infusion, diagnostic and multidisciplinary care teams.
Hematologist-oncologists may focus on leukemia, lymphoma, multiple myeloma, myelodysplastic disorders and related blood cancers.
Radiation oncologists work with medical physicists, dosimetrists, therapists, administrators and technology teams to plan and deliver radiation treatment.
Surgical oncologists participate in tumor-specific surgery, multidisciplinary planning, perioperative care and procedural program leadership.
Pediatric oncology programs may include oncologists, hematologists, surgeons, research teams, nurses and specialized children’s-hospital leadership.
Gynecologic oncologists manage ovarian, uterine, cervical, vulvar and related cancers through surgery, systemic therapy and coordinated specialty care.
Tumor-focused audience design
Tumor-type segmentation helps align specialists, clinical programs and organizations with the cancer area most relevant to the campaign.
Breast oncologists, breast surgeons, imaging teams and cancer-program leaders.
Thoracic oncologists, pulmonology-linked teams, radiation specialists and researchers.
GU oncologists, urologic oncologists, radiation oncologists and program directors.
GI oncologists, colorectal surgeons, pathologists and clinical research teams.
Melanoma specialists, surgical oncologists, dermatology-linked teams and researchers.
Leukemia, lymphoma, myeloma and transplant specialists.
Gynecologic oncologists, women’s cancer centers and program administrators.
GI oncologists, hepatobiliary specialists, surgeons and multidisciplinary teams.
GU medical oncologists, urologic oncologists and related treatment programs.
Neuro-oncologists, neurosurgeons, radiation teams and research programs.
Head-and-neck oncologists, surgeons, radiation specialists and care coordinators.
Sarcoma specialists, academic centers, research teams and referral programs.
Multidisciplinary cancer care
Cancer programs may involve multiple specialties and operational functions. Audience selection should identify which members of the team are clinically relevant, commercially influential or responsible for implementation.
The database concerns professional and organizational business contacts. It does not include patient names, diagnoses, genetic results, treatment histories, claims or confidential health information.
Care-setting segmentation
Organization type can influence buying authority, treatment complexity, research activity, staffing and vendor-review processes.
Multidisciplinary centers may combine clinical programs, infusion, radiation, diagnostics, research and administrative leadership.
Physician owners, managing partners and practice administrators.
Department chairs, medical directors and hospital operational teams.
Radiation oncologists, physicists, administrators and technology teams.
Clinical managers, nursing leaders, pharmacy contacts and administrators.
Faculty, investigators, research directors and trial operations teams.
Pediatric oncologists, program leaders and children’s-hospital teams.
A treatment, diagnostic, research or operational requirement is identified.
Clinical evidence, guidelines, intended use and safety considerations are reviewed.
Relevant specialists assess clinical fit and impact on the cancer-care pathway.
Teams examine workflow, staffing, technology, pharmacy or laboratory requirements.
Budget, procurement, vendor, contract and compliance processes are completed.
Training, integration, education and operational adoption are coordinated.
Therapy and service alignment
Product-to-audience matching helps reduce irrelevant contacts and clarifies which clinical, research, pharmacy, operational or purchasing roles should be included.
Medical oncologists, tumor-focused specialists, pharmacy leaders and cancer-program directors.
Radiation oncologists, medical physicists, department leaders and procurement teams.
Oncologists, pathologists, molecular-diagnostics leaders and laboratory directors.
Principal investigators, research directors, trial coordinators and academic cancer centers.
Oncology nurses, infusion leaders, administrators and pharmacy decision-makers.
Cancer-program administrators, practice managers, clinical leaders and healthcare IT teams.
Decision-maker directory
Build the audience around the people who guide clinical programs, manage operations, oversee research, direct pharmacy services or approve purchasing.
Research audience segmentation
Research and precision-oncology contacts can be separated from routine clinical-care audiences for trial recruitment, diagnostics, genomics, technology, education and partnership outreach.
Request a Research-Focused Audience →Professional and organization data
Final columns depend on the selected discipline, tumor focus, organization type, geography and available professional-record coverage.
Field availability varies. Not every field is available for every professional or organization record.
Audience planning studio
These examples show how discipline, tumor type, care setting, geography and role can be combined around a specific business purpose.
Transparent audience preparation
The preparation process begins with the business requirement and ends with a confirmed scope, field structure and delivery format.
Clarify the campaign, intended audience and exclusions.
Separate medical, radiation, surgical, hematology and other oncology disciplines.
Identify relevant cancer specialties where available.
Distinguish practices, hospitals, cancer centers, research sites and treatment facilities.
Select clinical, research, leadership, operational and purchasing roles.
Standardize selected fields and apply relevant duplicate rules.
Confirm available counts, columns and audience boundaries.
Prepare the agreed Excel or CSV format.
Oncology professionals may change titles, affiliations, departments and business-contact details. No professional database remains permanently complete or error-free. Available coverage and fields should be reviewed against the selected criteria.
Read the Data Quality Approach →Frequently asked questions
It is a customized professional contact database covering oncologists, cancer-center leaders, research professionals and other relevant healthcare business contacts.
Audiences may include medical oncologists, hematologist-oncologists, radiation oncologists, surgical oncologists, pediatric oncologists, gynecologic oncologists and other identified oncology specialties.
Yes, when available professional information supports the requested discipline classification.
Yes. Hematologist-oncologists and identified blood-cancer specialists may be selected separately.
Yes. Tumor-focus filters may include breast, lung, prostate, colorectal, blood, gynecologic, GI, GU, brain, melanoma and other identified cancer areas.
Yes. Chiefs of oncology, medical directors, department chairs, cancer-program directors and administrators may be included where identified.
Yes. Principal investigators, research directors, coordinators, translational-oncology professionals and clinical trial sites may be selected.
Yes. Organization type and care setting may be used as segmentation criteria where available.
Yes. Oncology pharmacy directors and related pharmacy leadership may be included when relevant and identifiable.
Audiences may be requested by country, state, city, ZIP code, region or defined sales territory, subject to available coverage.
Fields may include name, title, oncology discipline, tumor focus, organization, department, business email, phone, website and location. Availability varies by record.
No. Patient names, diagnoses, genetic information, treatment histories, medical claims and confidential health information are not supplied.
A representative sample may be provided to demonstrate audience structure, available fields and formatting.
It may support relevant B2B marketing, recruitment, education, research, event promotion and supplier outreach, subject to applicable requirements and the Medico Lists Data Use Policy.
Oncology audience planning desk
Share the oncology disciplines, tumor focus, care settings, research roles, leadership contacts, geographic markets and fields required for the project. Medico Lists will review the criteria and provide the available audience scope.